Xenon Pharma
423 employees on LinkedIn · 2 known investors
Xenon is a neuroscience-focused biopharmaceutical company that discovers and develops ion channel modulators as therapeutics for neurological and psychiatric disorders. Its pipeline includes a Phase 3 program in epilepsy and depression for its lead candidate azetukalner, along with early-stage pain programs targeting sodium and potassium channels.
Founders & leadership
IM
Ian MortimerinPresident and Chief Executive Officer
DC
Darren ClineChief Commercial Officer
AD
Andrea DiFabioChief Legal Officer and Corporate Secretary
JE
James EmpfieldExecutive Vice President, Drug Discovery
TK
Tucker KellyChief Financial Officer
CK
Chris KenneyChief Medical Officer
SM
Shelley McCloskeyExecutive Vice President, Human Resources
MD
Matthew D. RonsheimChief Operating Officer
RS
Robin SherringtonExecutive Vice President, Strategy and Innovation
Investors · 2
Frequently asked questions
- What does Xenon Pharma do?
- Xenon is a neuroscience-focused biopharmaceutical company that discovers and develops ion channel modulators as therapeutics for neurological and psychiatric disorders. Its pipeline includes a Phase 3 program in epilepsy and depression for its lead candidate azetukalner, along with early-stage pain programs targeting sodium and potassium channels.
- Who are Xenon Pharma's investors?
- Xenon Pharma's investors include Avoro Capital Advisors, New Enterprise Associates (NEA).